Overview
The Biomedical Acceleration and Commercialization Center (BACC) at Albany Medical College focuses on turning bio-discovery into real healthcare products and services. It runs an ecosystem that brings together entrepreneurs, inventors, academic researchers, and students to refine technologies, access resources and facilities, and connect with mentors and industry experts to grow biotech ventures. Unlike groups that only do research or funding, BACC provides hands-on support, space, and connections to help ideas move toward commercial development and broader patient impact. Its goal is to discover, develop, and accelerate breakthrough biotechnologies that improve patient experiences and outcomes while contributing to regional economic growth.
Work here?Claim your company
Simplify's take
What believers are saying
- Matthew C. Jones became acting CEO November 4, 2026, restoring day-to-day control.
- A national CEO search signals a reset and board-level commitment to stabilization.
- The BACC still offers founders labs, clinical access, and commercialization support.
What critics are saying
- Daniel Pickett was fired November 4, 2026, triggering leadership instability.
- Holley et al. v. Albany Medical College filed August 20, 2026 adds malpractice exposure.
- Governance shock and scandal can derail recruiting, donations, and BACC partner trust by 2027.
What makes Albany Medical College unique
- Albany Medical College anchors Albany Med Health System and the BACC innovation pipeline.
- Its regional network spans Albany, Saratoga, Hudson, and Glens Falls.
- The BACC combines academic medicine, entrepreneurship, and commercialization under one institutional roof.
Help us improve and share your feedback! Did you find this helpful?